NY-WEA-GRP-POLICIES
5.5.2022 13:07:06 CEST | Business Wire | Press release
The Women’s Entrepreneurship Accelerator (WEA) today announced the publication of an Advocacy Brief titled “Procurement’s strategic value: Why gender-responsive procurement makes business sense” which presents compelling evidence of the benefits for strengthening the participation of women in private sector supply chains in realizing inclusive economic growth and sustainable development.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220505005120/en/
Developed by UN Women and funded by Mary Kay Inc. in support of WEA, the Advocacy Brief highlights the rollback on progress in achieving gender equality as a result of the COVID-19 pandemic, as well as how increasing levels of economic insecurity, supply chain interruptions and unprecedented climate and environmental shocks have a disproportionate impact on women given their unequal position in society.
The publication echoes previous studies that show that economies have better opportunities to grow and are more resilient to crises if women and men have equal rights.1 However, huge challenges remain. Women entrepreneurs continue to face many obstacles including lack of access to capital on both domestic and international markets; fewer entrepreneurship networks compared with men; and policies that discourage female labor market participation.2 Globally, while one in three businesses are owned by women, 3 women only win an estimated one percent of the global spend of large corporations .4 Unequal gender laws also hinder women’s economic opportunity. For instance, nearly 2.4 billion women of working age still do not enjoy the same economic rights as men.5 Despite these statistics, women entrepreneurs remain a solution for many challenges the world faces today and the evidence shows there is a direct correlation between an increase in women entrepreneurship and economic growth, sustainable development, and more inclusive and resilient societies.6
The data presented in the Advocacy Brief outline how the adoption of gender-responsive (GRP) policies and practices through procurement processes is a strategic lever to mitigate the impact of the structural barriers women face and at the same time improve businesses and strengthen economies. The Advocacy Brief cautions that failing to adopt GRP is a wasted opportunity. The evidence is clear. Reducing gender inequalities is good for business and is smart economics.
“Gender-responsive procurement affects corporate profitability, risk mitigation, innovation, and sustainability. When women entrepreneurs are excluded from the procurement pipeline, companies risk leaving a considerable amount of talent, creativity, and expertise on the table. GRP is a winning business strategy as well as a powerful catalyst for change,” said Deborah Gibbins, Chief Operating Officer, Mary Kay, Inc., and inceptor of WEA.
To inform the Advocacy Brief, UN Women engaged over 350 stakeholders in 2021, of which over 150 private sector companies were represented, and incorporated 7 case studies on companies’ procurement journeys to create an evidence base for why businesses should adopt gender-responsive procurement. Stakeholder engagement took the form of interviews, a survey and a community of practice, which benefitted from dissemination across a wide range of networks, including the membership and networks of UN Global Compact’s (UNGC).
Companies reported that GRP leads to:
- Increased revenue and reduced procurement spend,
- Greater supplier availability and resilience,
- Strengthened brand reputation,
- More innovation and adaptability,
- Improved service delivery due to greater agility, and
- Strengthened markets through local economic development and inclusive growth.
As the Advocacy Brief notes “inclusive and sustainable development is paramount for businesses seeking to both stabilize themselves in a volatile economy and benefit from its future growth. Widening gender inequalities hurt all companies, including women entrepreneurs vital to robust and resilient supply chains and the businesses that rely on them.”
Reflecting the increased focus on environmental, social and governance (ESG) issues by companies, the Advocacy Brief notes how “the implementation of GRP allows companies to practice and institutionalize ESG values and importantly contribute to women’s empowerment and the Sustainable Development Goals (SDGs). Through the adoption of GRP principles, businesses can make progress towards multiple goals, including gender equality (SDG 5) and reduced inequalities (SDG 10) in addition to responsible consumption and production (SDG 12), eliminating poverty (SDG 1) and decent work and economic growth (SDG 8).”
“Achieving the Sustainable Development Goals is not something that can be done by women alone, or by business alone, or by government alone. The only way for us to be able to really make progress is if all – business included – work together towards a common purpose,” said Anita Bhatia , Assistant Secretary-General and Deputy Executive Director of UN Women.
Through the release of this report WEA calls on the private sector to adopt GRP strategies and integrate women into global value chains as a vehicle to advance the SDGs. This makes business sense while at the same time advances women’s economic empowerment which benefits economies and societies at large.
The Advocacy Brief is available here .
About the Women’s Entrepreneurship Accelerator
The Women’s Entrepreneurship Accelerator (WEA) is a multi-stakeholder partnership on women’s entrepreneurship established during UNGA 74. It convenes six UN agencies, International Labour Organization (ILO), International Trade Centre (ITC), International Telecommunication Union (ITU), UN Development Programme (UNDP), UN Global Compact (UNGC), UN Women and Mary Kay Inc. to empower 5 million women entrepreneurs by 2030.
The ultimate goal of the initiative is to maximize the development impact of women entrepreneurship in achieving the Sustainable Development Goals (SDGs) by creating an enabling ecosystem for women entrepreneurs around the world. The Accelerator exemplifies the transformational power of a multi-partnership of unique magnitude to harness the potential of women entrepreneurs. Learn more at we-accelerate. Follow us: Twitter (We_Accelerator), Instagram (@we_accelerator), Facebook (@womensentrepreneurshipaccelerator), LinkedIn (@womensentrepreneurshipaccelerator)
1 World Development Report. 2012: Gender Equality and Development: https://openknowledge.worldbank.org/handle/10986/4391 . |
2 European Commission and OECD Policy Brief on Women’s Entrepreneurship. 2017: https://www.oecd.org/cfe/smes/Policy-Brief-on-Women-s-Entrepreneurship.pdf |
3 World Bank. 2020. Enterprise Surveys, World Bank Gender Data Portal: https://www.worldbank.org/en/data/datatopics/gender |
4 Vazquez, E.A. and A.J. Sherman. 2013. Buying for Impact: How to Buy from Women and Change the World. Charleston, USA: Advantage |
5 World Bank Group. 2022.. Women, Business and the Law 2022. Washington, DC: World Bank |
6 UN Women Facts and Figures: Economic Empowerment: https://www.unwomen.org/en/what-we-do/economic-empowerment/facts-and-figures |
View source version on businesswire.com: https://www.businesswire.com/news/home/20220505005120/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
